Healthcare - Biotechnology - NASDAQ - US
$ 0.803
-4.02 %
$ 3.45 M
Market Cap
-0.05
P/E
CASH FLOW STATEMENT
-7.29 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
14 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Revelation Biosciences, Inc.
| Net Income | -120 K |
| Depreciation & Amortization | 25 K |
| Capital Expenditures | -4 |
| Stock-Based Compensation | 156 K |
| Change in Working Capital | 982 K |
| Others | -8.1 M |
| Free Cash Flow | -7.29 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (0.1) | (10.8) | (12.0) | (1.6) | 3.64 K |
| Depreciation & Amortization | 25 K | 25 K | 16.8 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.3 | 0.5 | 43.8 K | 0 |
| Other Operating Activities | (8.3) | 15 K | 52.4 K | 1.5 | 0 |
| Change in Working Capital | 1.0 | (0.7) | 0.4 | 80.5 K | 3.64 K |
| Cash From Operations | (7.3) | (11.2) | (11.1) | (0.2) | 0 |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 4 | 0 | (0.1) | 0 | 0 |
| Other Items | 4 | 0 | 0 | (74.0) | 0 |
| Cash From Investing Activities | 0 | 0 | (0.1) | (74.0) | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 5 K | (7.7) | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (0.8) | 0 | 15 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.97 K | 11.5 | 7.4 | (65.4) | 10 K |
| Cash From Financing Activities | 14.0 | 15.2 | 8.0 | 74.3 | 0 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 6.7 | 4.0 | (3.2) | (74.2) | 0 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (7.3) | (11.2) | (11.2) | (0.2) | 0 |